{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:28:33Z","timestamp":1792794513884,"version":"4.5.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10555-021-10004-4","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T08:02:49Z","timestamp":1638432169000},"page":"1093-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets"],"prefix":"10.1007","volume":"40","author":[{"given":"Henriette Berg","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Ialchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3044-7714","authenticated-orcid":false,"given":"Stine Falsig","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Czaplinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"10004_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014). Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research, 74, 2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155","journal-title":"Cancer Research"},{"key":"10004_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020). Metabolism of pancreatic cancer: Paving the way to better anticancer strategies. Molecular Cancer, 19, 50. https:\/\/doi.org\/10.1186\/s12943-020-01169-7","journal-title":"Molecular Cancer"},{"key":"10004_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., Kong, B., Fu, D.-L., Bruns, C., Zhao, Y., Qin, L.-X., & Dong, Q.-Z. (2021). The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives. Signal Transduction and Targeted Therapy, 6, 249. https:\/\/doi.org\/10.1038\/s41392-021-00659-4","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10004_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein, A. N., Brekken, R. A., & Maitra, A. (2020). Pancreatic cancer stroma: An update on therapeutic targeting strategies. Nature Reviews. Gastroenterology & Hepatology, 17, 487\u2013505. https:\/\/doi.org\/10.1038\/s41575-020-0300-1","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10004_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S1470-2045(17)30314-5","volume":"18","author":"A Alistar","year":"2017","unstructured":"Alistar, A., Morris, B. B., Desnoyer, R., Klepin, H. D., Hosseinzadeh, K., Clark, C., Cameron, A., Leyendecker, J., D\u2019Agostino, R., Topaloglu, U., Boteju, L. W., Boteju, A. R., Shorr, R., Zachar, Z., Bingham, P. M., Ahmed, T., Crane, S., Shah, R., Migliano, J. J., \u2026 Pasche, B. (2017). Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: A single-centre, open-label, dose-escalation, phase 1 trial. The lancet Oncology, 18, 770\u2013778. https:\/\/doi.org\/10.1016\/S1470-2045(17)30314-5","journal-title":"The lancet Oncology"},{"key":"10004_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.gendis.2015.07.003","volume":"2","author":"Y Jia","year":"2015","unstructured":"Jia, Y., & Xie, J. (2015). Promising molecular mechanisms responsible for gemcitabine resistance in cancer. Genes Dis., 2, 299\u2013306. https:\/\/doi.org\/10.1016\/j.gendis.2015.07.003","journal-title":"Genes Dis."},{"key":"10004_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cmet.2017.04.004","volume":"25","author":"AC Kimmelman","year":"2017","unstructured":"Kimmelman, A. C., & White, E. (2017). Autophagy and tumor metabolism. Cell Metabolism, 25, 1037\u20131043. https:\/\/doi.org\/10.1016\/j.cmet.2017.04.004","journal-title":"Cell Metabolism"},{"key":"10004_CR8","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012). The pancreas cancer microenvironment. Clinical Cancer Research, 18, 4266\u20134276. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-3114","journal-title":"Clinical Cancer Research"},{"key":"10004_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","volume":"31","author":"CJ Halbrook","year":"2017","unstructured":"Halbrook, C. J., & Lyssiotis, C. A. (2017). Employing metabolism to improve the diagnosis and treatment of pancreatic cancer. Cancer Cell, 31, 5\u201319. https:\/\/doi.org\/10.1016\/j.ccell.2016.12.006","journal-title":"Cancer Cell"},{"key":"10004_CR10","doi-asserted-by":"publisher","first-page":"1600253","DOI":"10.1002\/bies.201600253","volume":"39","author":"SF Pedersen","year":"2017","unstructured":"Pedersen, S. F., Novak, I., Alves, F., Schwab, A., & Pardo, L. A. (2017). Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. BioEssays, 39, 1600253. https:\/\/doi.org\/10.1002\/bies.201600253","journal-title":"BioEssays"},{"key":"10004_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2867-13-89","volume":"13","author":"Y Kato","year":"2013","unstructured":"Kato, Y., Ozawa, S., Miyamoto, C., Maehata, Y., Suzuki, A., Maeda, T., & Baba, Y. (2013). Acidic extracellular microenvironment and cancer. Cancer Cell International, 13, 89. https:\/\/doi.org\/10.1186\/1475-2867-13-89","journal-title":"Cancer Cell International"},{"key":"10004_CR12","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1038\/srep04410","volume":"4","author":"Z Cruz-Monserrate","year":"2015","unstructured":"Cruz-Monserrate, Z., Roland, C. L., Deng, D., Arumugam, T., Moshnikova, A., Andreev, O. A., Reshetnyak, Y. K., & Logsdon, C. D. (2015). Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Science and Reports, 4, 4410. https:\/\/doi.org\/10.1038\/srep04410","journal-title":"Science and Reports"},{"key":"10004_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2012.569","volume":"108","author":"PP Provenzano","year":"2013","unstructured":"Provenzano, P. P., & Hingorani, S. R. (2013). Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. British Journal of Cancer, 108, 1\u20138. https:\/\/doi.org\/10.1038\/bjc.2012.569","journal-title":"British Journal of Cancer"},{"key":"10004_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.critrevonc.2017.03.026","volume":"114","author":"C Grasso","year":"2017","unstructured":"Grasso, C., Jansen, G., & Giovannetti, E. (2017). Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology Hematology, 114, 139\u2013152. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.026","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"10004_CR15","doi-asserted-by":"publisher","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","volume":"112","author":"A Daemen","year":"2015","unstructured":"Daemen, A., Peterson, D., Sahu, N., McCord, R., Du, X., Liu, B., Kowanetz, K., Hong, R., Moffat, J., Gao, M., Boudreau, A., Mroue, R., Corson, L., O\u2019Brien, T., Qing, J., Sampath, D., Merchant, M., Yauch, R., Manning, G., \u2026 Evangelista, M. (2015). Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proceedings of the National Academy of Sciences, 112, E4410\u2013E4417. https:\/\/doi.org\/10.1073\/pnas.1501605112","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10004_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nature13611","volume":"514","author":"A Viale","year":"2014","unstructured":"Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., S\u00e1nchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., Deem, A. K., Kapoor, A., Yao, W., Brunetto, E., \u2026 Draetta, G. F. (2014). Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature, 514, 628\u2013632. https:\/\/doi.org\/10.1038\/nature13611","journal-title":"Nature"},{"key":"10004_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1078-0432.CCR-19-1543","volume":"26","author":"JM Karasinska","year":"2020","unstructured":"Karasinska, J. M., Topham, J. T., Kalloger, S. E., Jang, G. H., Denroche, R. E., Culibrk, L., Williamson, L. M., Wong, H.-L., Lee, M. K. C., O\u2019Kane, G. M., Moore, R. A., Mungall, A. J., Moore, M. J., Warren, C., Metcalfe, A., Notta, F., Knox, J. J., Gallinger, S., Laskin, J., \u2026 Schaeffer, D. F. (2020). Altered gene expression along the glycolysis\u2013cholesterol synthesis axis is associated with outcome in pancreatic cancer. Clinical Cancer Research, 26, 135\u2013146. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1543","journal-title":"Clinical Cancer Research"},{"key":"10004_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bbabio.2016.12.003","volume":"2017","author":"V Zecchini","year":"1858","unstructured":"Zecchini, V., & Frezza, C. (1858). Metabolic synthetic lethality in cancer therapy. Biochim. Biophys. Acta BBA - Bioenerg., 2017, 723\u2013731. https:\/\/doi.org\/10.1016\/j.bbabio.2016.12.003","journal-title":"Biochim. Biophys. Acta BBA - Bioenerg."},{"key":"10004_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd.2018.123","volume":"17","author":"MT Villanueva","year":"2018","unstructured":"Villanueva, M. T. (2018). Metabolic synthetic lethality. Nature Reviews. Drug Discovery, 17, 543\u2013543. https:\/\/doi.org\/10.1038\/nrd.2018.123","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10004_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.7150\/thno.40195","volume":"10","author":"SS Kim","year":"2020","unstructured":"Kim, S. S., Xu, S., Cui, J., Poddar, S., Le, T. M., Hayrapetyan, H., Li, L., Wu, N., Moore, A. M., Zhou, L., Yu, A. C., Dann, A. M., Elliott, I. A., Abt, E. R., Kim, W., Dawson, D. W., Radu, C. G., & Donahue, T. R. (2020). Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression. Theranostics., 10, 829\u2013840. https:\/\/doi.org\/10.7150\/thno.40195","journal-title":"Theranostics."},{"key":"10004_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/bjc.2014.272","volume":"111","author":"G Cheng","year":"2014","unstructured":"Cheng, G., Zielonka, J., McAllister, D., Tsai, S., Dwinell, M. B., & Kalyanaraman, B. (2014). Profiling and targeting of cellular bioenergetics: Inhibition of pancreatic cancer cell proliferation. British Journal of Cancer, 111, 85\u201393. https:\/\/doi.org\/10.1038\/bjc.2014.272","journal-title":"British Journal of Cancer"},{"key":"10004_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/bib\/bby026","volume":"20","author":"L Zhao","year":"2019","unstructured":"Zhao, L., Lee, V. H. F., Ng, M. K., Yan, H., & Bijlsma, M. F. (2019). Molecular subtyping of cancer: Current status and moving toward clinical applications. Briefings in Bioinformatics, 20, 572\u2013584. https:\/\/doi.org\/10.1093\/bib\/bby026","journal-title":"Briefings in Bioinformatics"},{"key":"10004_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., & Lander, E. S. (1999). Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science, 286, 531\u2013537. https:\/\/doi.org\/10.1126\/science.286.5439.531","journal-title":"Science"},{"key":"10004_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02825415","volume":"18","author":"C Caldas","year":"1995","unstructured":"Caldas, C., & Kern, S. E. (1995). K-ras mutation and pancreatic adenocarcinoma. International Journal of Pancreatology, 18, 1\u20136. https:\/\/doi.org\/10.1007\/BF02825415","journal-title":"International Journal of Pancreatology"},{"key":"10004_CR25","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., Feiler, H. S., Ko, A. H., Olshen, A. B., Danenberg, K. L., Tempero, M. A., Spellman, P. T., Hanahan, D., & Gray, J. W. (2011). Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nature Medicine, 17, 500\u2013503. https:\/\/doi.org\/10.1038\/nm.2344","journal-title":"Nature Medicine"},{"key":"10004_CR26","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., Smyla, J. K., Anderson, J. M., Kim, H. J., Bentrem, D. J., Talamonti, M. S., Iacobuzio-Donahue, C. A., Hollingsworth, M. A., & Yeh, J. J. (2015). Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nature Genetics, 47, 1168\u20131178. https:\/\/doi.org\/10.1038\/ng.3398","journal-title":"Nature Genetics"},{"key":"10004_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Australian Pancreatic Cancer Genome Initiative, Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, L., \u2026 Grimmond, S. M. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature., 531, 47\u201352. https:\/\/doi.org\/10.1038\/nature16965","journal-title":"Nature."},{"key":"10004_CR28","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo, F., Nicolle, R., Blum, Y., Cros, J., Marisa, L., Demetter, P., Quertinmont, E., Svrcek, M., Elarouci, N., Iovanna, J., Franchimont, D., Verset, L., Galdon, M. G., Devi\u00e8re, J., de Reyni\u00e8s, A., Laurent-Puig, P., Van Laethem, J.-L., Bachet, J.-B., & Mar\u00e9chal, R. (2018). Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology, 155, 1999-2013.e3. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.033","journal-title":"Gastroenterology"},{"key":"10004_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nm.4038","volume":"22","author":"EM Noll","year":"2016","unstructured":"Noll, E. M., Eisen, C., Stenzinger, A., Espinet, E., Muckenhuber, A., Klein, C., Vogel, V., Klaus, B., Nadler, W., R\u00f6sli, C., Lutz, C., Kulke, M., Engelhardt, J., Zickgraf, F. M., Espinosa, O., Schlesner, M., Jiang, X., Kopp-Schneider, A., Neuhaus, P., \u2026 Sprick, M. R. (2016). CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nature Medicine, 22, 278\u2013287. https:\/\/doi.org\/10.1038\/nm.4038","journal-title":"Nature Medicine"},{"key":"10004_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s12885-018-4546-8","volume":"18","author":"L Zhao","year":"2018","unstructured":"Zhao, L., Zhao, H., & Yan, H. (2018). Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes. BMC Cancer, 18, 603. https:\/\/doi.org\/10.1186\/s12885-018-4546-8","journal-title":"BMC Cancer"},{"key":"10004_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J., & Chandel, N. S. (2016). Fundamentals of cancer metabolism. Science Advances, 2, e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200","journal-title":"Science Advances"},{"key":"10004_CR32","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/aps.2016.47","volume":"37","author":"X Chen","year":"2016","unstructured":"Chen, X., Li, L., Guan, Y., Yang, J., & Cheng, Y. (2016). Anticancer strategies based on the metabolic profile of tumor cells: Therapeutic targeting of the Warburg effect. Acta Pharmacologica Sinica, 37, 1013\u20131019. https:\/\/doi.org\/10.1038\/aps.2016.47","journal-title":"Acta Pharmacologica Sinica"},{"key":"10004_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., Yan, H., Wang, W., Chen, S., Viale, A., Zheng, H., Paik, J., Lim, C., Guimaraes, A. R., Martin, E. S., \u2026 DePinho, R. A. (2012). Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell, 149, 656\u2013670. https:\/\/doi.org\/10.1016\/j.cell.2012.01.058","journal-title":"Cell"},{"key":"10004_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S., & Schulze, A. (2020). Greasing the wheels of the cancer machine: The role of lipid metabolism in cancer. Cell Metabolism, 31, 62\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.010","journal-title":"Cell Metabolism"},{"key":"10004_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cancers10010003","volume":"10","author":"Y Sunami","year":"2017","unstructured":"Sunami, Y., Rebelo, A., & Kleeff, J. (2017). Lipid metabolism and lipid droplets in pancreatic cancer and stellate cells. Cancers, 10, 3. https:\/\/doi.org\/10.3390\/cancers10010003","journal-title":"Cancers"},{"key":"10004_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/carcin\/bgt053","volume":"34","author":"S Yabushita","year":"2013","unstructured":"Yabushita, S., Fukamachi, K., Tanaka, H., Fukuda, T., Sumida, K., Deguchi, Y., Mikata, K., Nishioka, K., Kawamura, S., Uwagawa, S., Suzui, M., Alexander, D. B., & Tsuda, H. (2013). Metabolomic and transcriptomic profiling of human K- ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Carcinogenesis, 34, 1251\u20131259. https:\/\/doi.org\/10.1093\/carcin\/bgt053","journal-title":"Carcinogenesis"},{"key":"10004_CR37","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","volume":"77","author":"S Tadros","year":"2017","unstructured":"Tadros, S., Shukla, S. K., King, R. J., Gunda, V., Vernucci, E., Abrego, J., Chaika, N. V., Yu, F., Lazenby, A. J., Berim, L., Grem, J., Sasson, A. R., & Singh, P. K. (2017). De Novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer. Cancer Research, 77, 5503\u20135517. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3062","journal-title":"Cancer Research"},{"key":"10004_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell, 8, 311\u2013321. https:\/\/doi.org\/10.1016\/j.ccr.2005.09.008","journal-title":"Cancer Cell"},{"key":"10004_CR39","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1073\/pnas.1307237110","volume":"110","author":"JJ Kamphorst","year":"2013","unstructured":"Kamphorst, J. J., Cross, J. R., Fan, J., de Stanchina, E., Mathew, R., White, E. P., Thompson, C. B., & Rabinowitz, J. D. (2013). Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proceedings of the National Academy of Sciences, 110, 8882\u20138887. https:\/\/doi.org\/10.1073\/pnas.1307237110","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10004_CR40","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1073\/pnas.1421601112","volume":"112","author":"F Guillaumond","year":"2015","unstructured":"Guillaumond, F., Bidaut, G., Ouaissi, M., Servais, S., Gouirand, V., Olivares, O., Lac, S., Borge, L., Roques, J., Gayet, O., Pinault, M., Guimaraes, C., Nigri, J., Loncle, C., Lavaut, M.-N., Garcia, S., Tailleux, A., Staels, B., Calvo, E., \u2026 Vasseur, S. (2015). Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proceedings of the National Academy of Sciences, 112, 2473\u20132478. https:\/\/doi.org\/10.1073\/pnas.1421601112","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10004_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","volume":"38","author":"L Gabitova-Cornell","year":"2020","unstructured":"Gabitova-Cornell, L., Surumbayeva, A., Peri, S., Franco-Barraza, J., Restifo, D., Weitz, N., Ogier, C., Goldman, A. R., Hartman, T. R., Francescone, R., Tan, Y., Nicolas, E., Shah, N., Handorf, E. A., Cai, K. Q., O\u2019Reilly, A. M., Sloma, I., Chiaverelli, R., Moffitt, R. A., \u2026 Astsaturov, I. (2020). Cholesterol pathway inhibition induces TGF-\u03b2 signaling to promote basal differentiation in pancreatic cancer. Cancer Cell, 38, 567-583.e11. https:\/\/doi.org\/10.1016\/j.ccell.2020.08.015","journal-title":"Cancer Cell"},{"key":"10004_CR42","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1158\/0008-5472.CAN-20-1255","volume":"80","author":"CN Rozeveld","year":"2020","unstructured":"Rozeveld, C. N., Johnson, K. M., Zhang, L., & Razidlo, G. L. (2020). KRAS controls pancreatic cancer cell lipid metabolism and invasive potential through the lipase HSL. Cancer Research, 80, 4932\u20134945. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1255","journal-title":"Cancer Research"},{"key":"10004_CR43","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","volume":"21","author":"AC Kimmelman","year":"2015","unstructured":"Kimmelman, A. C. (2015). Metabolic dependencies in RAS -driven cancers. Clinical Cancer Research, 21, 1828\u20131834. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2425","journal-title":"Clinical Cancer Research"},{"key":"10004_CR44","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/bjc.2012.310","volume":"107","author":"K Kaira","year":"2012","unstructured":"Kaira, K., Sunose, Y., Arakawa, K., Ogawa, T., Sunaga, N., Shimizu, K., Tominaga, H., Oriuchi, N., Itoh, H., Nagamori, S., Kanai, Y., Segawa, A., Furuya, M., Mori, M., Oyama, T., & Takeyoshi, I. (2012). Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer. British Journal of Cancer, 107, 632\u2013638. https:\/\/doi.org\/10.1038\/bjc.2012.310","journal-title":"British Journal of Cancer"},{"key":"10004_CR45","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1111\/bph.13616","volume":"173","author":"V Coothankandaswamy","year":"2016","unstructured":"Coothankandaswamy, V., Cao, S., Xu, Y., Prasad, P. D., Singh, P. K., Reynolds, C. P., Yang, S., Ogura, J., Ganapathy, V., & Bhutia, Y. D. (2016). Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer: SLC6A14 is a drug target for pancreatic cancer. British Journal of Pharmacology, 173, 3292\u20133306. https:\/\/doi.org\/10.1111\/bph.13616","journal-title":"British Journal of Pharmacology"},{"key":"10004_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise, D. R., & Thompson, C. B. (2010). Glutamine addiction: A new therapeutic target in cancer. Trends in Biochemical Sciences, 35, 427\u2013433. https:\/\/doi.org\/10.1016\/j.tibs.2010.05.003","journal-title":"Trends in Biochemical Sciences"},{"key":"10004_CR47","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1172\/JCI69600","volume":"123","author":"CT Hensley","year":"2013","unstructured":"Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013). Glutamine and cancer: Cell biology, physiology, and clinical opportunities. The Journal of Clinical Investigation, 123, 3678\u20133684. https:\/\/doi.org\/10.1172\/JCI69600","journal-title":"The Journal of Clinical Investigation"},{"key":"10004_CR48","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1073\/pnas.1219555110","volume":"110","author":"F Guillaumond","year":"2013","unstructured":"Guillaumond, F., Leca, J., Olivares, O., Lavaut, M.-N., Vidal, N., Berthezene, P., Dusetti, N. J., Loncle, C., Calvo, E., Turrini, O., Iovanna, J. L., Tomasini, R., & Vasseur, S. (2013). Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proceedings of the National Academy of Sciences, 110, 3919\u20133924. https:\/\/doi.org\/10.1073\/pnas.1219555110","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10004_CR49","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3389\/fonc.2019.00848","volume":"9","author":"E Pupo","year":"2019","unstructured":"Pupo, E., Avanzato, D., Middonti, E., Bussolino, F., & Lanzetti, L. (2019). KRAS-driven metabolic rewiring reveals novel actionable targets in cancer. Frontiers in Oncology, 9, 848. https:\/\/doi.org\/10.3389\/fonc.2019.00848","journal-title":"Frontiers in Oncology"},{"key":"10004_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., Kang, Y., Fleming, J. B., Bardeesy, N., Asara, J. M., Haigis, M. C., DePinho, R. A., Cantley, L. C., & Kimmelman, A. C. (2013). Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature, 496, 101\u2013105. https:\/\/doi.org\/10.1038\/nature12040","journal-title":"Nature"},{"key":"10004_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2017.04.029","volume":"400","author":"J Abrego","year":"2017","unstructured":"Abrego, J., Gunda, V., Vernucci, E., Shukla, S. K., King, R. J., Dasgupta, A., Goode, G., Murthy, D., Yu, F., & Singh, P. K. (2017). GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Cancer Letters, 400, 37\u201346. https:\/\/doi.org\/10.1016\/j.canlet.2017.04.029","journal-title":"Cancer Letters"},{"key":"10004_CR52","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/clinchem\/47.8.1467","volume":"47","author":"A Pastore","year":"2001","unstructured":"Pastore, A., Piemonte, F., Locatelli, M., Lo Russo, A., Gaeta, L. M., Tozzi, G., & Federici, G. (2001). Determination of blood total, reduced, and oxidized glutathione in pediatric subjects. Clin. Chem., 47, 1467\u20131469.","journal-title":"Clin. Chem."},{"key":"10004_CR53","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41556-019-0407-1","volume":"21","author":"VM-Y Wang","year":"2019","unstructured":"Wang, V.M.-Y., Ferreira, R. M. M., Almagro, J., Evan, T., Legrave, N., Zaw Thin, M., Frith, D., Carvalho, J., Barry, D. J., Snijders, A. P., Herbert, E., Nye, E. L., MacRae, J. I., & Behrens, A. (2019). CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth. Nat. Cell Biol., 21, 1425\u20131435. https:\/\/doi.org\/10.1038\/s41556-019-0407-1","journal-title":"Nat. Cell Biol."},{"key":"10004_CR54","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature12138","volume":"497","author":"C Commisso","year":"2013","unstructured":"Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., Rabinowitz, J. D., Metallo, C. M., Vander Heiden, M. G., & Bar-Sagi, D. (2013). Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature., 497, 633\u2013637. https:\/\/doi.org\/10.1038\/nature12138","journal-title":"Nature."},{"key":"10004_CR55","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nm.3686","volume":"20","author":"JR Mayers","year":"2014","unstructured":"Mayers, J. R., Wu, C., Clish, C. B., Kraft, P., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., Davidson, S. M., Papagiannakopoulos, T., Yang, A., Dayton, T. L., Ogino, S., Stampfer, M. J., Giovannucci, E. L., Qian, Z. R., Rubinson, D. A., \u2026 Wolpin, B. M. (2014). Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat. Med., 20, 1193\u20131198. https:\/\/doi.org\/10.1038\/nm.3686","journal-title":"Nat. Med."},{"key":"10004_CR56","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-18-3855","volume":"79","author":"B Daher","year":"2019","unstructured":"Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouyss\u00e9gur, J., & Vu\u010deti\u0107, M. (2019). Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival, and tumor formation via nutrient and oxidative stresses. Cancer Research, 79, 3877\u20133890. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3855","journal-title":"Cancer Research"},{"key":"10004_CR57","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/ncomms16031","volume":"8","author":"O Olivares","year":"2017","unstructured":"Olivares, O., Mayers, J. R., Gouirand, V., Torrence, M. E., Gicquel, T., Borge, L., Lac, S., Roques, J., Lavaut, M.-N., Berthez\u00e8ne, P., Rubis, M., Secq, V., Garcia, S., Moutardier, V., Lombardo, D., Iovanna, J. L., Tomasini, R., Guillaumond, F., Vander Heiden, M. G., & Vasseur, S. (2017). Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat. Commun., 8, 16031. https:\/\/doi.org\/10.1038\/ncomms16031","journal-title":"Nat. Commun."},{"key":"10004_CR58","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41467-017-00331-y","volume":"8","author":"T Zaytouni","year":"2017","unstructured":"Zaytouni, T., Tsai, P.-Y., Hitchcock, D. S., DuBois, C. D., Freinkman, E., Lin, L., Morales-Oyarvide, V., Lenehan, P. J., Wolpin, B. M., Mino-Kenudson, M., Torres, E. M., Stylopoulos, N., Clish, C. B., & Kalaany, N. Y. (2017). Critical role for arginase 2 in obesity-associated pancreatic cancer. Nature Communications, 8, 242. https:\/\/doi.org\/10.1038\/s41467-017-00331-y","journal-title":"Nature Communications"},{"key":"10004_CR59","doi-asserted-by":"publisher","unstructured":"M. New, T. Van Acker, J.S. Long, J. Sakamaki, K.M. Ryan, S.A. Tooze, Molecular pathways controlling autophagy in pancreatic cancer, Front. Oncol. 7 (2017). https:\/\/doi.org\/10.3389\/fonc.2017.00028.","DOI":"10.3389\/fonc.2017.00028"},{"key":"10004_CR60","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/onc.2016.333","volume":"36","author":"EE Mowers","year":"2017","unstructured":"Mowers, E. E., Sharifi, M. N., & Macleod, K. F. (2017). Autophagy in cancer metastasis. Oncogene, 36, 1619\u20131630. https:\/\/doi.org\/10.1038\/onc.2016.333","journal-title":"Oncogene"},{"key":"10004_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature14587","volume":"524","author":"RM Perera","year":"2015","unstructured":"Perera, R. M., Stoykova, S., Nicolay, B. N., Ross, K. N., Fitamant, J., Boukhali, M., Lengrand, J., Deshpande, V., Selig, M. K., Ferrone, C. R., Settleman, J., Stephanopoulos, G., Dyson, N. J., Zoncu, R., Ramaswamy, S., Haas, W., & Bardeesy, N. (2015). Transcriptional control of autophagy\u2013lysosome function drives pancreatic cancer metabolism. Nature, 524, 361\u2013365. https:\/\/doi.org\/10.1038\/nature14587","journal-title":"Nature"},{"key":"10004_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12964-018-0242-1","volume":"16","author":"M Yang","year":"2018","unstructured":"Yang, M., Liu, E., Tang, L., Lei, Y., Sun, X., Hu, J., Dong, H., Yang, S.-M., Gao, M., & Tang, B. (2018). Emerging roles and regulation of MiT\/TFE transcriptional factors. Cell Communication and Signaling: CCS, 16, 31. https:\/\/doi.org\/10.1186\/s12964-018-0242-1","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10004_CR63","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41591-019-0367-9","volume":"25","author":"CG Kinsey","year":"2019","unstructured":"Kinsey, C. G., Camolotto, S. A., Boespflug, A. M., Guillen, K. P., Foth, M., Truong, A., Schuman, S. S., Shea, J. E., Seipp, M. T., Yap, J. T., Burrell, L. D., Lum, D. H., Whisenant, J. R., Gilcrease, G. W., Cavalieri, C. C., Rehbein, K. M., Cutler, S. L., Affolter, K. E., Welm, A. L., \u2026 McMahon, M. (2019). Protective autophagy elicited by RAF\u2192MEK\u2192ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nature Medicine, 25, 620\u2013627. https:\/\/doi.org\/10.1038\/s41591-019-0367-9","journal-title":"Nature Medicine"},{"key":"10004_CR64","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2021.02.016","volume":"39","author":"H Su","year":"2021","unstructured":"Su, H., Yang, F., Fu, R., Li, X., French, R., Mose, E., Pu, X., Trinh, B., Kumar, A., Liu, J., Antonucci, L., Todoric, J., Liu, Y., Hu, Y., Diaz-Meco, M. T., Moscat, J., Metallo, C. M., Lowy, A. M., Sun, B., & Karin, M. (2021). Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis. Cancer Cell, 39, 678-693.e11. https:\/\/doi.org\/10.1016\/j.ccell.2021.02.016","journal-title":"Cancer Cell"},{"key":"10004_CR65","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaoncol.2019.0684","volume":"5","author":"TB Karasic","year":"2019","unstructured":"Karasic, T. B., O\u2019Hara, M. H., Loaiza-Bonilla, A., Reiss, K. A., Teitelbaum, U. R., Borazanci, E., De Jesus-Acosta, A., Redlinger, C., Burrell, J. A., Laheru, D. A., Von Hoff, D. D., Amaravadi, R. K., Drebin, J. A., & O\u2019Dwyer, P. J. (2019). Effect of gemcitabine and nab-paclitaxel with or without hydroxychloroquine on patients with advanced pancreatic cancer: A phase 2 randomized clinical trial. JAMA Oncology, 5, 993. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0684","journal-title":"JAMA Oncology"},{"key":"10004_CR66","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1101\/gad.287524.116","volume":"30","author":"R Amaravadi","year":"2016","unstructured":"Amaravadi, R., Kimmelman, A. C., & White, E. (2016). Recent insights into the function of autophagy in cancer. Genes & Development, 30, 1913\u20131930. https:\/\/doi.org\/10.1101\/gad.287524.116","journal-title":"Genes & Development"},{"key":"10004_CR67","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41416-020-01039-5","volume":"124","author":"M Piffoux","year":"2021","unstructured":"Piffoux, M., Eriau, E., & Cassier, P. A. (2021). Autophagy as a therapeutic target in pancreatic cancer. British Journal of Cancer, 124, 333\u2013344. https:\/\/doi.org\/10.1038\/s41416-020-01039-5","journal-title":"British Journal of Cancer"},{"key":"10004_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41419-020-03324-w","volume":"12","author":"A-L Tian","year":"2021","unstructured":"Tian, A.-L., Wu, Q., Liu, P., Zhao, L., Martins, I., Kepp, O., Leduc, M., & Kroemer, G. (2021). Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response. Cell Death & Disease, 12, 6. https:\/\/doi.org\/10.1038\/s41419-020-03324-w","journal-title":"Cell Death & Disease"},{"key":"10004_CR69","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","volume":"18","author":"SR Bonam","year":"2019","unstructured":"Bonam, S. R., Wang, F., & Muller, S. (2019). Lysosomes as a therapeutic target. Nature Reviews. Drug Discovery, 18, 923\u2013948. https:\/\/doi.org\/10.1038\/s41573-019-0036-1","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10004_CR70","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/2159-8290.CD-14-0049","volume":"4","author":"JMM Levy","year":"2014","unstructured":"Levy, J. M. M., Thompson, J. C., Griesinger, A. M., Amani, V., Donson, A. M., Birks, D. K., Morgan, M. J., Mirsky, D. M., Handler, M. H., Foreman, N. K., & Thorburn, A. (2014). Autophagy inhibition improves chemosensitivity in BRAF V600E brain tumors. Cancer Discovery, 4, 773\u2013780. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0049","journal-title":"Cancer Discovery"},{"key":"10004_CR71","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-019-0368-8","volume":"25","author":"KL Bryant","year":"2019","unstructured":"Bryant, K. L., Stalnecker, C. A., Zeitouni, D., Klomp, J. E., Peng, S., Tikunov, A. P., Gunda, V., Pierobon, M., Waters, A. M., George, S. D., Tomar, G., Papke, B., Hobbs, G. A., Yan, L., Hayes, T. K., Diehl, J. N., Goode, G. D., Chaika, N. V., Wang, Y., \u2026 Der, C. J. (2019). Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nature Medicine, 25, 628\u2013640. https:\/\/doi.org\/10.1038\/s41591-019-0368-8","journal-title":"Nature Medicine"},{"key":"10004_CR72","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1073\/pnas.1817494116","volume":"116","author":"C-S Lee","year":"2019","unstructured":"Lee, C.-S., Lee, L. C., Yuan, T. L., Chakka, S., Fellmann, C., Lowe, S. W., Caplen, N. J., McCormick, F., & Luo, J. (2019). MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival. Proceedings of the National Academy of Sciences, 116, 4508\u20134517. https:\/\/doi.org\/10.1073\/pnas.1817494116","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10004_CR73","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-019-1577-5","volume":"573","author":"JP Morris","year":"2019","unstructured":"Morris, J. P., Yashinskie, J. J., Koche, R., Chandwani, R., Tian, S., Chen, C.-C., Baslan, T., Marinkovic, Z. S., S\u00e1nchez-Rivera, F. J., Leach, S. D., Carmona-Fontaine, C., Thompson, C. B., Finley, L. W. S., & Lowe, S. W. (2019). \u03b1-Ketoglutarate links p53 to cell fate during tumour suppression. Nature, 573, 595\u2013599. https:\/\/doi.org\/10.1038\/s41586-019-1577-5","journal-title":"Nature"},{"key":"10004_CR74","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1038\/s41467-018-07472-8","volume":"9","author":"N Santana-Codina","year":"2018","unstructured":"Santana-Codina, N., Roeth, A. A., Zhang, Y., Yang, A., Mashadova, O., Asara, J. M., Wang, X., Bronson, R. T., Lyssiotis, C. A., Ying, H., & Kimmelman, A. C. (2018). Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nature Communications, 9, 4945. https:\/\/doi.org\/10.1038\/s41467-018-07472-8","journal-title":"Nature Communications"},{"key":"10004_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109238","volume":"35","author":"T Schild","year":"2021","unstructured":"Schild, T., McReynolds, M. R., Shea, C., Low, V., Schaffer, B. E., Asara, J. M., Piskounova, E., Dephoure, N., Rabinowitz, J. D., Gomes, A. P., & Blenis, J. (2021). NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma. Cell Reports, 35, 109238. https:\/\/doi.org\/10.1016\/j.celrep.2021.109238","journal-title":"Cell Reports"},{"key":"10004_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.05.024","volume":"379","author":"H-Q Ju","year":"2016","unstructured":"Ju, H.-Q., Zhuang, Z.-N., Li, H., Tian, T., Lu, Y.-X., Fan, X.-Q., Zhou, H.-J., Mo, H.-Y., Sheng, H., Chiao, P. J., & Xu, R.-H. (2016). Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer. Cancer Letters, 379, 1\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2016.05.024","journal-title":"Cancer Letters"},{"key":"10004_CR77","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2016.04.033","volume":"165","author":"S Kugel","year":"2016","unstructured":"Kugel, S., Sebasti\u00e1n, C., Fitamant, J., Ross, K. N., Saha, S. K., Jain, E., Gladden, A., Arora, K. S., Kato, Y., Rivera, M. N., Ramaswamy, S., Sadreyev, R. I., Goren, A., Deshpande, V., Bardeesy, N., & Mostoslavsky, R. (2016). SIRT6 suppresses pancreatic cancer through control of Lin28b. Cell, 165, 1401\u20131415. https:\/\/doi.org\/10.1016\/j.cell.2016.04.033","journal-title":"Cell"},{"key":"10004_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrm4007","volume":"16","author":"F Kruiswijk","year":"2015","unstructured":"Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015). p53 in survival, death and metabolic health: A lifeguard with a licence to kill. Nature Reviews Molecular Cell Biology, 16, 393\u2013405. https:\/\/doi.org\/10.1038\/nrm4007","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10004_CR79","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1158\/0008-5472.CAN-03-0846","volume":"64","author":"F Schwartzenberg-Bar-Yoseph","year":"2004","unstructured":"Schwartzenberg-Bar-Yoseph, F., Armoni, M., & Karnieli, E. (2004). The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Research, 64, 2627\u20132633. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-0846","journal-title":"Cancer Research"},{"key":"10004_CR80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell, 126, 107\u2013120. https:\/\/doi.org\/10.1016\/j.cell.2006.05.036","journal-title":"Cell"},{"key":"10004_CR81","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1158\/0008-5472.CAN-15-0108","volume":"75","author":"NV Rajeshkumar","year":"2015","unstructured":"Rajeshkumar, N. V., Dutta, P., Yabuuchi, S., de Wilde, R. F., Martinez, G. V., Le, A., Kamphorst, J. J., Rabinowitz, J. D., Jain, S. K., Hidalgo, M., Dang, C. V., Gillies, R. J., & Maitra, A. (2015). Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function. Cancer Research, 75, 3355\u20133364. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0108","journal-title":"Cancer Research"},{"key":"10004_CR82","doi-asserted-by":"publisher","first-page":"97422","DOI":"10.1172\/jci.insight.97422","volume":"3","author":"HK Schofield","year":"2018","unstructured":"Schofield, H. K., Zeller, J., Espinoza, C., Halbrook, C. J., Del Vecchio, A., Magnuson, B., Fabo, T., Daylan, A. E. C., Kovalenko, I., Lee, H.-J., Yan, W., Feng, Y., Karim, S. A., Kremer, D. M., Kumar-Sinha, C., Lyssiotis, C. A., Ljungman, M., Morton, J. P., Galb\u00e1n, S., \u2026 Pasca di Magliano, M. (2018). Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma. JCI Insight., 3, 97422. https:\/\/doi.org\/10.1172\/jci.insight.97422","journal-title":"JCI Insight."},{"key":"10004_CR83","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2017.07.014","volume":"67","author":"A Nagarajan","year":"2017","unstructured":"Nagarajan, A., Dogra, S. K., Sun, L., Gandotra, N., Ho, T., Cai, G., Cline, G., Kumar, P., Cowles, R. A., & Wajapeyee, N. (2017). Paraoxonase 2 facilitates pancreatic cancer growth and metastasis by stimulating GLUT1-mediated glucose transport. Molecular Cell, 67, 685-701.e6. https:\/\/doi.org\/10.1016\/j.molcel.2017.07.014","journal-title":"Molecular Cell"},{"key":"10004_CR84","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","volume":"69","author":"C Liang","year":"2020","unstructured":"Liang, C., Shi, S., Qin, Y., Meng, Q., Hua, J., Hu, Q., Ji, S., Zhang, B., Xu, J., & Yu, X.-J. (2020). Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut, 69, 888\u2013900. https:\/\/doi.org\/10.1136\/gutjnl-2018-317163","journal-title":"Gut"},{"key":"10004_CR85","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/s41388-021-01726-4","volume":"40","author":"Z Ezrova","year":"2021","unstructured":"Ezrova, Z., Nahacka, Z., Stursa, J., Werner, L., Vlcak, E., Kralova Viziova, P., Berridge, M. V., Sedlacek, R., Zobalova, R., Rohlena, J., Boukalova, S., & Neuzil, J. (2021). SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy. Oncogene., 40, 2539\u20132552. https:\/\/doi.org\/10.1038\/s41388-021-01726-4","journal-title":"Oncogene."},{"key":"10004_CR86","doi-asserted-by":"publisher","first-page":"14437","DOI":"10.1038\/ncomms14437","volume":"8","author":"H-Q Ju","year":"2017","unstructured":"Ju, H.-Q., Ying, H., Tian, T., Ling, J., Fu, J., Lu, Y., Wu, M., Yang, L., Achreja, A., Chen, G., Zhuang, Z., Wang, H., Nagrath, D., Yao, J., Hung, M.-C., DePinho, R. A., Huang, P., Xu, R.-H., & Chiao, P. J. (2017). Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nature Communications, 8, 14437. https:\/\/doi.org\/10.1038\/ncomms14437","journal-title":"Nature Communications"},{"key":"10004_CR87","doi-asserted-by":"publisher","first-page":"e44235","DOI":"10.7554\/eLife.44235","volume":"8","author":"MR Sullivan","year":"2019","unstructured":"Sullivan, M. R., Danai, L. V., Lewis, C. A., Chan, S. H., Gui, D. Y., Kunchok, T., Dennstedt, E. A., Vander Heiden, M. G., & Muir, A. (2019). Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. ELife., 8, e44235. https:\/\/doi.org\/10.7554\/eLife.44235","journal-title":"ELife."},{"key":"10004_CR88","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet, C., & Feron, O. (2017). Tumour acidosis: From the passenger to the driver\u2019s seat. Nature Reviews Cancer, 17, 577\u2013593. https:\/\/doi.org\/10.1038\/nrc.2017.77","journal-title":"Nature Reviews Cancer"},{"key":"10004_CR89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer, E., & Pedersen, S. F. (2020). The acidic tumor microenvironment as a driver of cancer. Annual Review of Physiology, 82, 103\u2013126. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034627","journal-title":"Annual Review of Physiology"},{"key":"10004_CR90","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","volume":"11","author":"C Corbet","year":"2020","unstructured":"Corbet, C., Bastien, E., Santiago de Jesus, J. P., Dierge, E., Martherus, R., Vander Linden, C., Doix, B., Degavre, C., Guilbaud, C., Petit, L., Michiels, C., Dessy, C., Larondelle, Y., & Feron, O. (2020). TGF\u03b22-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells. Nat. Commun., 11, 454. https:\/\/doi.org\/10.1038\/s41467-019-14262-3","journal-title":"Nat. Commun."},{"key":"10004_CR91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2049-3002-1-23","volume":"1","author":"G LaMonte","year":"2013","unstructured":"LaMonte, G., Tang, X., Chen, J.L.-Y., Wu, J., Ding, C.-K.C., Keenan, M. M., Sangokoya, C., Kung, H.-N., Ilkayeva, O., Boros, L. G., Newgard, C. B., & Chi, J.-T. (2013). Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer Metab., 1, 23. https:\/\/doi.org\/10.1186\/2049-3002-1-23","journal-title":"Cancer Metab."},{"key":"10004_CR92","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1158\/0008-5472.CAN-14-0705","volume":"74","author":"C Corbet","year":"2014","unstructured":"Corbet, C., Draoui, N., Polet, F., Pinto, A., Drozak, X., Riant, O., & Feron, O. (2014). The SIRT1\/HIF2\u03b1 axis drives reductive glutamine metabolism under chronic acidosis and alters tumor response to therapy. Cancer Research, 74, 5507\u20135519. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0705","journal-title":"Cancer Research"},{"key":"10004_CR93","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.3390\/ijms22105209","volume":"22","author":"SF Pedersen","year":"2021","unstructured":"Pedersen, S. F., Flinck, M., & Pardo, L. A. (2021). The interplay between dysregulated ion transport and mitochondrial architecture as a dangerous liaison in cancer. International Journal of Molecular Sciences, 22, 5209. https:\/\/doi.org\/10.3390\/ijms22105209","journal-title":"International Journal of Molecular Sciences"},{"key":"10004_CR94","doi-asserted-by":"publisher","first-page":"e126915","DOI":"10.1172\/jci.insight.126915","volume":"4","author":"M Yu","year":"2019","unstructured":"Yu, M., Nguyen, N. D., Huang, Y., Lin, D., Fujimoto, T. N., Molkentine, J. M., Deorukhkar, A., Kang, Y., San Lucas, F. A., Fernandes, C. J., Koay, E. J., Gupta, S., Ying, H., Koong, A. C., Herman, J. M., Fleming, J. B., Maitra, A., & Taniguchi, C. M. (2019). Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight., 4, e126915. https:\/\/doi.org\/10.1172\/jci.insight.126915","journal-title":"JCI Insight."},{"key":"10004_CR95","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0360-3016(00)00803-8","volume":"48","author":"AC Koong","year":"2000","unstructured":"Koong, A. C., Mehta, V. K., Le, Q. T., Fisher, G. A., Terris, D. J., Brown, J. M., Bastidas, A. J., & Vierra, M. (2000). Pancreatic tumors show high levels of hypoxia. Int. J. Radiat. Oncol., 48, 919\u2013922. https:\/\/doi.org\/10.1016\/S0360-3016(00)00803-8","journal-title":"Int. J. Radiat. Oncol."},{"key":"10004_CR96","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","volume":"21","author":"CJ Whatcott","year":"2015","unstructured":"Whatcott, C. J., Diep, C. H., Jiang, P., Watanabe, A., LoBello, J., Sima, C., Hostetter, G., Shepard, H. M., Von Hoff, D. D., & Han, H. (2015). Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clinical Cancer Research, 21, 3561\u20133568. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1051","journal-title":"Clinical Cancer Research"},{"key":"10004_CR97","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1038\/oncsis.2017.54","volume":"6","author":"AJ Rice","year":"2017","unstructured":"Rice, A. J., Cortes, E., Lachowski, D., Cheung, B. C. H., Karim, S. A., Morton, J. P., & del R\u00edo Hern\u00e1ndez, A. (2017). Matrix stiffness induces epithelial\u2013mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis., 6, e352\u2013e352. https:\/\/doi.org\/10.1038\/oncsis.2017.54","journal-title":"Oncogenesis."},{"key":"10004_CR98","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1039\/C6IB00135A","volume":"8","author":"AV Nguyen","year":"2016","unstructured":"Nguyen, A. V., Nyberg, K. D., Scott, M. B., Welsh, A. M., Nguyen, A. H., Wu, N., Hohlbauch, S. V., Geisse, N. A., Gibb, E. A., Robertson, A. G., Donahue, T. R., & Rowat, A. C. (2016). Stiffness of pancreatic cancer cells is associated with increased invasive potential. Integrative Biology, 8, 1232\u20131245. https:\/\/doi.org\/10.1039\/C6IB00135A","journal-title":"Integrative Biology"},{"key":"10004_CR99","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nm.4099","volume":"22","author":"N Rath","year":"2016","unstructured":"Rath, N., & Olson, M. F. (2016). Regulation of pancreatic cancer aggressiveness by stromal stiffening. Nature Medicine, 22, 462\u2013463. https:\/\/doi.org\/10.1038\/nm.4099","journal-title":"Nature Medicine"},{"key":"10004_CR100","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s42255-019-0165-1","volume":"2","author":"MV Liberti","year":"2020","unstructured":"Liberti, M. V., & Birsoy, K. (2020). A link between metabolic energetics and pancreatic cancer mechanosensing. Nature Metabolism, 2, 5\u20136. https:\/\/doi.org\/10.1038\/s42255-019-0165-1","journal-title":"Nature Metabolism"},{"key":"10004_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.631991","volume":"11","author":"H Ge","year":"2021","unstructured":"Ge, H., Tian, M., Pei, Q., Tan, F., & Pei, H. (2021). Extracellular matrix stiffness: New areas affecting cell metabolism. Frontiers in Oncology, 11, 631991. https:\/\/doi.org\/10.3389\/fonc.2021.631991","journal-title":"Frontiers in Oncology"},{"key":"10004_CR102","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccr.2014.05.026","volume":"25","author":"J Gore","year":"2014","unstructured":"Gore, J., & Korc, M. (2014). Pancreatic cancer stroma: Friend or foe? Cancer Cell, 25, 711\u2013712. https:\/\/doi.org\/10.1016\/j.ccr.2014.05.026","journal-title":"Cancer Cell"},{"key":"10004_CR103","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","volume":"3","author":"A Maitra","year":"2008","unstructured":"Maitra, A., & Hruban, R. H. (2008). Pancreatic cancer. Annual Review of Pathology: Mechanisms of Disease, 3, 157\u2013188. https:\/\/doi.org\/10.1146\/annurev.pathmechdis.3.121806.154305","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10004_CR104","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gutjnl-2011-301220","volume":"61","author":"M Erkan","year":"2012","unstructured":"Erkan, M., Adler, G., Apte, M. V., Bachem, M. G., Buchholz, M., Detlefsen, S., Esposito, I., Friess, H., Gress, T. M., Habisch, H.-J., Hwang, R. F., Jaster, R., Kleeff, J., Kl\u00f6ppel, G., Kordes, C., Logsdon, C. D., Masamune, A., Michalski, C. W., Oh, J., \u2026 Wilson, J. (2012). StellaTUM: Current consensus and discussion on pancreatic stellate cell research. Gut, 61, 172\u2013178. https:\/\/doi.org\/10.1136\/gutjnl-2011-301220","journal-title":"Gut"},{"key":"10004_CR105","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fphys.2018.00754","volume":"9","author":"R Xue","year":"2018","unstructured":"Xue, R., Jia, K., Wang, J., Yang, L., Wang, Y., Gao, L., & Hao, J. (2018). A rising star in pancreatic diseases: Pancreatic stellate cells. Frontiers in Physiology, 9, 754. https:\/\/doi.org\/10.3389\/fphys.2018.00754","journal-title":"Frontiers in Physiology"},{"key":"10004_CR106","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1158\/2159-8290.CD-18-1212","volume":"9","author":"FR Auciello","year":"2019","unstructured":"Auciello, F. R., Bulusu, V., Oon, C., Tait-Mulder, J., Berry, M., Bhattacharyya, S., Tumanov, S., Allen-Petersen, B. L., Link, J., Kendsersky, N. D., Vringer, E., Schug, M., Novo, D., Hwang, R. F., Evans, R. M., Nixon, C., Dorrell, C., Morton, J. P., Norman, J. C., \u2026 Sherman, M. H. (2019). A stromal lysolipid\u2013autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discovery, 9, 617\u2013627. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1212","journal-title":"Cancer Discovery"},{"key":"10004_CR107","doi-asserted-by":"publisher","first-page":"G408","DOI":"10.1152\/ajpgi.00016.2013","volume":"305","author":"MV Apte","year":"2013","unstructured":"Apte, M. V., Yang, L., Phillips, P. A., Xu, Z., Kaplan, W., Cowley, M., Pirola, R. C., & Wilson, J. S. (2013). Extracellular matrix composition significantly influences pancreatic stellate cell gene expression pattern: Role of transgelin in PSC function, Am. J. Physiol.-Gastrointest. Liver Physiol., 305, G408\u2013G417. https:\/\/doi.org\/10.1152\/ajpgi.00016.2013","journal-title":"Liver Physiol."},{"key":"10004_CR108","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L., Kremer, D., Hwang, R. F., Witkiewicz, A. K., Ying, H., Asara, J. M., Evans, R. M., Cantley, L. C., Lyssiotis, C. A., & Kimmelman, A. C. (2016). Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature, 536, 479\u2013483. https:\/\/doi.org\/10.1038\/nature19084","journal-title":"Nature"},{"key":"10004_CR109","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","volume":"10","author":"E Helms","year":"2020","unstructured":"Helms, E., Onate, M. K., & Sherman, M. H. (2020). Fibroblast heterogeneity in the pancreatic tumor microenvironment. Cancer Discovery, 10, 648\u2013656. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1353","journal-title":"Cancer Discovery"},{"key":"10004_CR110","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fonc.2019.00356","volume":"9","author":"X Yang","year":"2019","unstructured":"Yang, X., Li, Y., Zou, L., & Zhu, Z. (2019). Role of exosomes in crosstalk between cancer-associated fibroblasts and cancer cells. Frontiers in Oncology, 9, 356. https:\/\/doi.org\/10.3389\/fonc.2019.00356","journal-title":"Frontiers in Oncology"},{"key":"10004_CR111","doi-asserted-by":"publisher","first-page":"100","DOI":"10.7150\/ijbs.22555","volume":"14","author":"S Chen","year":"2018","unstructured":"Chen, S., Chen, X., Shan, T., Ma, J., Lin, W., Li, W., & Kang, Y. (2018). MiR-21-mediated metabolic alteration of cancer-associated fibroblasts and its effect on pancreatic cancer cell behavior. International Journal of Biological Sciences, 14, 100\u2013110. https:\/\/doi.org\/10.7150\/ijbs.22555","journal-title":"International Journal of Biological Sciences"},{"key":"10004_CR112","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1172\/JCI59227","volume":"122","author":"MA Collins","year":"2012","unstructured":"Collins, M. A., Bednar, F., Zhang, Y., Brisset, J.-C., Galb\u00e1n, S., Galb\u00e1n, C. J., Rakshit, S., Flannagan, K. S., Adsay, N. V., & Pasca di Magliano, M. (2012). Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. The Journal of Clinical Investigation, 122, 639\u2013653. https:\/\/doi.org\/10.1172\/JCI59227","journal-title":"The Journal of Clinical Investigation"},{"key":"10004_CR113","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","volume":"18","author":"N Ricard","year":"2021","unstructured":"Ricard, N., Bailly, S., Guignabert, C., & Simons, M. (2021). The quiescent endothelium: Signalling pathways regulating organ-specific endothelial normalcy. Nature Reviews. Cardiology, 18, 565\u2013580. https:\/\/doi.org\/10.1038\/s41569-021-00517-4","journal-title":"Nature Reviews. Cardiology"},{"key":"10004_CR114","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","volume":"154","author":"K De Bock","year":"2013","unstructured":"De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesqui\u00e8re, B., Cauwenberghs, S., Eelen, G., Phng, L.-K., Betz, I., Tembuyser, B., Brepoels, K., Welti, J., Geudens, I., Segura, I., Cruys, B., Bifari, F., \u2026 Carmeliet, P. (2013). Role of PFKFB3-driven glycolysis in vessel sprouting. Cell, 154, 651\u2013663. https:\/\/doi.org\/10.1016\/j.cell.2013.06.037","journal-title":"Cell"},{"key":"10004_CR115","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nature13312","volume":"511","author":"B Ghesqui\u00e8re","year":"2014","unstructured":"Ghesqui\u00e8re, B., Wong, B. W., Kuchnio, A., & Carmeliet, P. (2014). Metabolism of stromal and immune cells in health and disease. Nature, 511, 167\u2013176. https:\/\/doi.org\/10.1038\/nature13312","journal-title":"Nature"},{"key":"10004_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046571","volume":"7","author":"CJ De Saedeleer","year":"2012","unstructured":"De Saedeleer, C. J., Copetti, T., Porporato, P. E., Verrax, J., Feron, O., & Sonveaux, P. (2012). Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells. PLoS ONE, 7, e46571. https:\/\/doi.org\/10.1371\/journal.pone.0046571","journal-title":"PLoS ONE"},{"key":"10004_CR117","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","volume":"71","author":"F V\u00e9gran","year":"2011","unstructured":"V\u00e9gran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011). Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-\u03baB\/IL-8 pathway that drives tumor angiogenesis. Cancer Research, 71, 2550\u20132560. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2828","journal-title":"Cancer Research"},{"key":"10004_CR118","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear, A. S., Vonderheide, R. H., & O\u2019Hara, M. H. (2020). Challenges and opportunities for pancreatic cancer immunotherapy. Cancer Cell, 38, 788\u2013802. https:\/\/doi.org\/10.1016\/j.ccell.2020.08.004","journal-title":"Cancer Cell"},{"key":"10004_CR119","doi-asserted-by":"publisher","unstructured":"E. Costello, The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion, Front. Physiol. 3 (2012). https:\/\/doi.org\/10.3389\/fphys.2012.00270.","DOI":"10.3389\/fphys.2012.00270"},{"key":"10004_CR120","doi-asserted-by":"publisher","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","volume":"67","author":"CE Clark","year":"2007","unstructured":"Clark, C. E., Hingorani, S. R., Mick, R., Combs, C., Tuveson, D. A., & Vonderheide, R. H. (2007). Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Research, 67, 9518\u20139527. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0175","journal-title":"Cancer Research"},{"key":"10004_CR121","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","volume":"164","author":"AK Palucka","year":"2016","unstructured":"Palucka, A. K., & Coussens, L. M. (2016). The Basis of Oncoimmunology. Cell, 164, 1233\u20131247. https:\/\/doi.org\/10.1016\/j.cell.2016.01.049","journal-title":"Cell"},{"key":"10004_CR122","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., & Hanahan, D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology, 2, 737\u2013744. https:\/\/doi.org\/10.1038\/35036374","journal-title":"Nature Cell Biology"},{"key":"10004_CR123","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","volume":"6","author":"Y Pylayeva-Gupta","year":"2016","unstructured":"Pylayeva-Gupta, Y., Das, S., Handler, J. S., Hajdu, C. H., Coffre, M., Koralov, S. B., & Bar-Sagi, D. (2016). IL35-producing B cells promote the development of pancreatic neoplasia. Cancer Discovery, 6, 247\u2013255. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0843","journal-title":"Cancer Discovery"},{"key":"10004_CR124","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., Xiang, J., Zhang, T., Theilen, T.-M., Garc\u00eda-Santos, G., Williams, C., Ararso, Y., Huang, Y., Rodrigues, G., Shen, T.-L., \u2026 Lyden, D. (2015). Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology, 17, 816\u2013826. https:\/\/doi.org\/10.1038\/ncb3169","journal-title":"Nature Cell Biology"},{"key":"10004_CR125","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., Cline, G. W., Phillips, A. J., & Medzhitov, R. (2014). Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature, 513, 559\u2013563. https:\/\/doi.org\/10.1038\/nature13490","journal-title":"Nature"},{"key":"10004_CR126","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., Renner, K., Timischl, B., Mackensen, A., Kunz-Schughart, L., Andreesen, R., Krause, S. W., & Kreutz, M. (2007). Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood, 109, 3812\u20133819. https:\/\/doi.org\/10.1182\/blood-2006-07-035972","journal-title":"Blood"},{"key":"10004_CR127","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013). Tumor-derived lactate modifies antitumor immune response: Effect on myeloid-derived suppressor cells and NK cells. The Journal of Immunology, 191, 1486\u20131495. https:\/\/doi.org\/10.4049\/jimmunol.1202702","journal-title":"The Journal of Immunology"},{"key":"10004_CR128","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","volume":"3","author":"F Hossain","year":"2015","unstructured":"Hossain, F., Al-Khami, A. A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., Rodriguez, P. C., & Ochoa, A. C. (2015). Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies, Cancer. Immunologic Research, 3, 1236\u20131247. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0036","journal-title":"Immunologic Research"},{"key":"10004_CR129","doi-asserted-by":"publisher","first-page":"e2779","DOI":"10.1038\/cddis.2017.192","volume":"8","author":"S-L Jian","year":"2017","unstructured":"Jian, S.-L., Chen, W.-W., Su, Y.-C., Su, Y.-W., Chuang, T.-H., Hsu, S.-C., & Huang, L.-R. (2017). Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis. Cell Death & Disease, 8, e2779\u2013e2779. https:\/\/doi.org\/10.1038\/cddis.2017.192","journal-title":"Cell Death & Disease"},{"key":"10004_CR130","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.semcancer.2012.01.011","volume":"22","author":"S Ostrand-Rosenberg","year":"2012","unstructured":"Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012). Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Seminars in Cancer Biology, 22, 275\u2013281. https:\/\/doi.org\/10.1016\/j.semcancer.2012.01.011","journal-title":"Seminars in Cancer Biology"},{"key":"10004_CR131","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","volume":"172","author":"S Kusmartsev","year":"2004","unstructured":"Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004). Antigen-specific inhibition of CD8 + T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. The Journal of Immunology, 172, 989\u2013999. https:\/\/doi.org\/10.4049\/jimmunol.172.2.989","journal-title":"The Journal of Immunology"},{"key":"10004_CR132","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-09-1230","volume":"16","author":"MJ Strouch","year":"2010","unstructured":"Strouch, M. J., Cheon, E. C., Salabat, M. R., Krantz, S. B., Gounaris, E., Melstrom, L. G., Dangi-Garimella, S., Wang, E., Munshi, H. G., Khazaie, K., & Bentrem, D. J. (2010). Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clinical Cancer Research, 16, 2257\u20132265. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1230","journal-title":"Clinical Cancer Research"},{"key":"10004_CR133","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.surg.2008.03.024","volume":"144","author":"E Angst","year":"2008","unstructured":"Angst, E., Reber, H. A., Hines, O. J., & Eibl, G. (2008). Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. Surgery., 144, 57\u201365. https:\/\/doi.org\/10.1016\/j.surg.2008.03.024","journal-title":"Surgery."},{"key":"10004_CR134","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"C-H Chang","year":"2015","unstructured":"Chang, C.-H., Qiu, J., O\u2019Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., Tonc, E., Schreiber, R. D., Pearce, E. J., & Pearce, E. L. (2015). Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell, 162, 1229\u20131241. https:\/\/doi.org\/10.1016\/j.cell.2015.08.016","journal-title":"Cell"},{"key":"10004_CR135","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010). Hypoxia-Inducible Factors and the Response to Hypoxic Stress. Molecular Cell, 40, 294\u2013309. https:\/\/doi.org\/10.1016\/j.molcel.2010.09.022","journal-title":"Molecular Cell"},{"key":"10004_CR136","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui, S., Ghergurovich, J. M., Morscher, R. J., Jang, C., Teng, X., Lu, W., Esparza, L. A., Reya, T., Le Zhan, J., Yanxiang Guo, E., & White, J.D. Rabinowitz. (2017). Glucose feeds the TCA cycle via circulating lactate. Nature., 551, 115\u2013118. https:\/\/doi.org\/10.1038\/nature24057","journal-title":"Nature."},{"key":"10004_CR137","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1038\/onc.2017.71","volume":"36","author":"TH Dovmark","year":"2017","unstructured":"Dovmark, T. H., Saccomano, M., Hulikova, A., Alves, F., & Swietach, P. (2017). Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells. Oncogene, 36, 4538\u20134550. https:\/\/doi.org\/10.1038\/onc.2017.71","journal-title":"Oncogene"},{"key":"10004_CR138","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1096\/fj.201700480r","volume":"32","author":"TH Dovmark","year":"2018","unstructured":"Dovmark, T. H., Hulikova, A., Niederer, S. A., Vaughan-Jones, R. D., & Swietach, P. (2018). Normoxic cells remotely regulate the acid-base balance of cells at the hypoxic core of connexin-coupled tumor growths. The FASEB Journal, 32, 83\u201396. https:\/\/doi.org\/10.1096\/fj.201700480r","journal-title":"The FASEB Journal"},{"key":"10004_CR139","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cmet.2020.03.001","volume":"31","author":"K Lund\u00f8","year":"2020","unstructured":"Lund\u00f8, K., Trauelsen, M., Pedersen, S. F., & Schwartz, T. W. (2020). Why Warburg works: Lactate controls immune evasion through GPR81. Cell Metabolism, 31, 666\u2013668. https:\/\/doi.org\/10.1016\/j.cmet.2020.03.001","journal-title":"Cell Metabolism"},{"key":"10004_CR140","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-14-0319","volume":"74","author":"CL Roland","year":"2014","unstructured":"Roland, C. L., Arumugam, T., Deng, D., Liu, S. H., Philip, B., Gomez, S., Burns, W. R., Ramachandran, V., Wang, H., Cruz-Monserrate, Z., & Logsdon, C. D. (2014). Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Research, 74, 5301\u20135310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0319","journal-title":"Cancer Research"},{"key":"10004_CR141","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo, M., Tsai, C.-H., Pucino, V., Ho, P.-C., & Mauro, C. (2021). Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nature Reviews Immunology, 21, 151\u2013161. https:\/\/doi.org\/10.1038\/s41577-020-0406-2","journal-title":"Nature Reviews Immunology"},{"key":"10004_CR142","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1158\/1078-0432.CCR-15-1883","volume":"22","author":"J Hutcheson","year":"2016","unstructured":"Hutcheson, J., Balaji, U., Porembka, M. R., Wachsmann, M. B., McCue, P. A., Knudsen, E. S., & Witkiewicz, A. K. (2016). Immunologic and metabolic features of pancreatic ductal adenocarcinoma define prognostic subtypes of disease. Clinical Cancer Research, 22, 3606\u20133617. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1883","journal-title":"Clinical Cancer Research"},{"key":"10004_CR143","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cell.2016.03.029","volume":"165","author":"CJ Tape","year":"2016","unstructured":"Tape, C. J., Ling, S., Dimitriadi, M., McMahon, K. M., Worboys, J. D., Leong, H. S., Norrie, I. C., Miller, C. J., Poulogiannis, G., Lauffenburger, D. A., & J\u00f8rgensen, C. (2016). Oncogenic KRAS regulates tumor cell signaling via stromal reciprocation. Cell, 165, 910\u2013920. https:\/\/doi.org\/10.1016\/j.cell.2016.03.029","journal-title":"Cell"},{"key":"10004_CR144","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms20184504","volume":"20","author":"P Zeng","year":"2019","unstructured":"Zeng, P. (2019). Lan, Gr\u00fctzmann, Pilarsky, Yang, Chemoresistance in pancreatic cancer. International Journal of Molecular Sciences, 20, 4504. https:\/\/doi.org\/10.3390\/ijms20184504","journal-title":"International Journal of Molecular Sciences"},{"key":"10004_CR145","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.ijrobp.2009.06.049","volume":"77","author":"D Schellenberg","year":"2010","unstructured":"Schellenberg, D., Quon, A., Minn, A. Y., Graves, E. E., Kunz, P., Ford, J. M., Fisher, G. A., Goodman, K. A., Koong, A. C., & Chang, D. T. (2010). 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. Int. J. Radiat. Oncol., 77, 1420\u20131425. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.049","journal-title":"Int. J. Radiat. Oncol."},{"key":"10004_CR146","doi-asserted-by":"publisher","first-page":"13787","DOI":"10.1073\/pnas.1203339109","volume":"109","author":"NV Chaika","year":"2012","unstructured":"Chaika, N. V., Gebregiworgis, T., Lewallen, M. E., Purohit, V., Radhakrishnan, P., Liu, X., Zhang, B., Mehla, K., Brown, R. B., Caffrey, T., Yu, F., Johnson, K. R., Powers, R., Hollingsworth, M. A., & Singh, P. K. (2012). MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proceedings of the National Academy of Sciences, 109, 13787\u201313792. https:\/\/doi.org\/10.1073\/pnas.1203339109","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10004_CR147","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1158\/1078-0432.CCR-17-1151","volume":"23","author":"V Gunda","year":"2017","unstructured":"Gunda, V., Souchek, J., Abrego, J., Shukla, S. K., Goode, G. D., Vernucci, E., Dasgupta, A., Chaika, N. V., King, R. J., Li, S., Wang, S., Yu, F., Bessho, T., Lin, C., & Singh, P. K. (2017). MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clinical Cancer Research, 23, 5881\u20135891. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1151","journal-title":"Clinical Cancer Research"},{"key":"10004_CR148","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.3390\/nu13093202","volume":"13","author":"NE Cortez","year":"2021","unstructured":"Cortez, N. E., & Mackenzie, G. G. (2021). Ketogenic diets in pancreatic cancer and associated cachexia: Cellular mechanisms and clinical perspectives. Nutrients, 13, 3202. https:\/\/doi.org\/10.3390\/nu13093202","journal-title":"Nutrients"},{"key":"10004_CR149","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","volume":"33","author":"DD Weber","year":"2020","unstructured":"Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020). Ketogenic diet in the treatment of cancer \u2013 Where do we stand? Mol. Metab., 33, 102\u2013121. https:\/\/doi.org\/10.1016\/j.molmet.2019.06.026","journal-title":"Mol. Metab."},{"key":"10004_CR150","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41586-021-04049-2","volume":"599","author":"EC Lien","year":"2021","unstructured":"Lien, E. C., Westermark, A. M., Zhang, Y., Yuan, C., Li, Z., Lau, A. N., Sapp, K. M., Wolpin, B. M., & Vander Heiden, M. G. (2021). Low glycaemic diets alter lipid metabolism to influence tumour growth. Nature., 599, 302\u2013307. https:\/\/doi.org\/10.1038\/s41586-021-04049-2","journal-title":"Nature."},{"key":"10004_CR151","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/srep02070","volume":"3","author":"B Salani","year":"2013","unstructured":"Salani, B., Marini, C., Rio, A. D., Ravera, S., Massollo, M., Orengo, A. M., Amaro, A., Passalacqua, M., Maffioli, S., Pfeffer, U., Cordera, R., Maggi, D., & Sambuceti, G. (2013). Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II. Science and Reports, 3, 2070. https:\/\/doi.org\/10.1038\/srep02070","journal-title":"Science and Reports"},{"key":"10004_CR152","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ygyno.2011.02.021","volume":"121","author":"A Yasmeen","year":"2011","unstructured":"Yasmeen, A., Beauchamp, M.-C., Piura, E., Segal, E., Pollak, M., & Gotlieb, W. H. (2011). Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins. Gynecologic Oncology, 121, 492\u2013498. https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.021","journal-title":"Gynecologic Oncology"},{"key":"10004_CR153","doi-asserted-by":"publisher","first-page":"27692","DOI":"10.1074\/jbc.M114.592576","volume":"289","author":"V Nair","year":"2014","unstructured":"Nair, V., Sreevalsan, S., Basha, R., Abdelrahim, M., Abudayyeh, A., Rodrigues Hoffman, A., & Safe, S. (2014). Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: Role of specificity protein (Sp) transcription factors. J. Biol. Chem., 289, 27692\u201327701. https:\/\/doi.org\/10.1074\/jbc.M114.592576","journal-title":"J. Biol. Chem."},{"key":"10004_CR154","doi-asserted-by":"publisher","first-page":"20441","DOI":"10.1038\/srep20441","volume":"6","author":"T Hart","year":"2016","unstructured":"Hart, T., Dider, S., Han, W., Xu, H., Zhao, Z., & Xie, L. (2016). Toward repurposing metformin as a precision anti-cancer therapy using structural systems pharmacology. Science and Reports, 6, 20441. https:\/\/doi.org\/10.1038\/srep20441","journal-title":"Science and Reports"},{"key":"10004_CR155","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41467-019-08582-7","volume":"10","author":"TMZ Waise","year":"2019","unstructured":"Waise, T. M. Z., Rasti, M., Duca, F. A., Zhang, S.-Y., Bauer, P. V., Rhodes, C. J., & Lam, T. K. T. (2019). Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production. Nature Communications, 10, 714. https:\/\/doi.org\/10.1038\/s41467-019-08582-7","journal-title":"Nature Communications"},{"key":"10004_CR156","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbrc.2015.05.043","volume":"463","author":"M Fares","year":"2015","unstructured":"Fares, M., Abedi-Valugerdi, M., Hassan, M., & Pot\u00e1cov\u00e1, Z. (2015). DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell line. Biochemical and Biophysical Research Communications, 463, 268\u2013274. https:\/\/doi.org\/10.1016\/j.bbrc.2015.05.043","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10004_CR157","doi-asserted-by":"publisher","first-page":"e19021","DOI":"10.1200\/jco.2010.28.15_suppl.e19021","volume":"28","author":"NA Doudican","year":"2010","unstructured":"Doudican, N. A., Pennell, R., Byron, S., Pollock, P., Liebes, L., Osman, I., & Orlow, S. (2010). Mebendazole in the treatment of melanoma: The role of Bcl-2 in predicting response and enhancing efficacy. Journal of Clinical Oncology, 28, e19021\u2013e19021. https:\/\/doi.org\/10.1200\/jco.2010.28.15_suppl.e19021","journal-title":"Journal of Clinical Oncology"},{"key":"10004_CR158","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cas.13442","volume":"109","author":"T Hirao","year":"2018","unstructured":"Hirao, T., Yamaguchi, M., Kikuya, M., Chibana, H., Ito, K., & Aoki, S. (2018). Altered intracellular signaling by imatinib increases the anti-cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells. Cancer Science, 109, 121\u2013131. https:\/\/doi.org\/10.1111\/cas.13442","journal-title":"Cancer Science"},{"key":"10004_CR159","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1038\/cddis.2013.44","volume":"4","author":"X-F Qi","year":"2013","unstructured":"Qi, X.-F., Zheng, L., Lee, K.-J., Kim, D.-H., Kim, C.-S., Cai, D.-Q., Wu, Z., Qin, J.-W., Yu, Y.-H., & Kim, S.-K. (2013). HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway. Cell Death & Disease, 4, e518\u2013e518. https:\/\/doi.org\/10.1038\/cddis.2013.44","journal-title":"Cell Death & Disease"},{"key":"10004_CR160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","volume":"73","author":"T Kimura","year":"2013","unstructured":"Kimura, T., Takabatake, Y., Takahashi, A., & Isaka, Y. (2013). Chloroquine in cancer therapy: A double-edged sword of autophagy. Cancer Research, 73, 3\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2464","journal-title":"Cancer Research"},{"key":"10004_CR161","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/neuonc\/nop046","volume":"12","author":"EL Kim","year":"2010","unstructured":"Kim, E. L., W\u00fcstenberg, R., R\u00fcbsam, A., Schmitz-Salue, C., Warnecke, G., B\u00fccker, E.-M., Pettkus, N., Speidel, D., Rohde, V., Schulz-Schaeffer, W., Deppert, W., & Giese, A. (2010). Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells. Neuro-Oncol., 12, 389\u2013400. https:\/\/doi.org\/10.1093\/neuonc\/nop046","journal-title":"Neuro-Oncol."},{"key":"10004_CR162","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.3390\/cancers13133230","volume":"13","author":"JC Garc\u00eda-Ca\u00f1averas","year":"2021","unstructured":"Garc\u00eda-Ca\u00f1averas, J. C., & Lahoz, A. (2021). Tumor microenvironment-derived metabolites: A guide to find new metabolic therapeutic targets and biomarkers. Cancers, 13, 3230. https:\/\/doi.org\/10.3390\/cancers13133230","journal-title":"Cancers"},{"key":"10004_CR163","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1101\/gad.1415606","volume":"20","author":"AF Hezel","year":"2006","unstructured":"Hezel, A. F. (2006). Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Development, 20, 1218\u20131249. https:\/\/doi.org\/10.1101\/gad.1415606","journal-title":"Genes & Development"},{"key":"10004_CR164","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1158\/1078-0432.CCR-14-0186","volume":"20","author":"M Shi","year":"2014","unstructured":"Shi, M., Cui, J., Du, J., Wei, D., Jia, Z., Zhang, J., Zhu, Z., Gao, Y., & Xie, K. (2014). A novel KLF4\/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer. Clinical Cancer Research, 20, 4370\u20134380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0186","journal-title":"Clinical Cancer Research"},{"key":"10004_CR165","first-page":"1731","volume":"57","author":"E Rozenblum","year":"1997","unstructured":"Rozenblum, E., Schutte, M., Goggins, M., Hahn, S. A., Panzer, S., Zahurak, M., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1997). Tumor-suppressive pathways in pancreatic carcinoma. Cancer Research, 57, 1731\u20131734.","journal-title":"Cancer Research"},{"key":"10004_CR166","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","volume":"17","author":"L Buscail","year":"2020","unstructured":"Buscail, L., Bournet, B., & Cordelier, P. (2020). Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nature Reviews. Gastroenterology & Hepatology, 17, 153\u2013168. https:\/\/doi.org\/10.1038\/s41575-019-0245-4","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10004_CR167","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford, S., Dawson, E., Forbes, S., Clements, J., Pettett, R., Dogan, A., Flanagan, A., Teague, J., Futreal, P. A., Stratton, M. R., & Wooster, R. (2004). The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. British Journal of Cancer, 91, 355\u2013358. https:\/\/doi.org\/10.1038\/sj.bjc.6601894","journal-title":"British Journal of Cancer"},{"key":"10004_CR168","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.celrep.2019.02.037","volume":"26","author":"XH Lowman","year":"2019","unstructured":"Lowman, X. H., Hanse, E. A., Yang, Y., Ishak Gabra, M. B., Tran, T. Q., Li, H., & Kong, M. (2019). p53 promotes cancer cell adaptation to glutamine deprivation by upregulating Slc7a3 to increase arginine uptake. Cell Rep., 26, 3051-3060.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.037","journal-title":"Cell Rep."},{"key":"10004_CR169","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1126863","volume":"312","author":"S Matoba","year":"2006","unstructured":"Matoba, S. (2006). p53 regulates mitochondrial respiration. Science, 312, 1650\u20131653. https:\/\/doi.org\/10.1126\/science.1126863","journal-title":"Science"},{"key":"10004_CR170","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/0008-5472.CAN-11-1215","volume":"72","author":"T Contractor","year":"2012","unstructured":"Contractor, T., & Harris, C. R. (2012). p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Research, 72, 560\u2013567. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1215","journal-title":"Cancer Research"},{"key":"10004_CR171","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ncb2172","volume":"13","author":"P Jiang","year":"2011","unstructured":"Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011). p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology, 13, 310\u2013316. https:\/\/doi.org\/10.1038\/ncb2172","journal-title":"Nature Cell Biology"},{"key":"10004_CR172","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/SLA.0b013e3182827a65","volume":"258","author":"M Oshima","year":"2013","unstructured":"Oshima, M., Okano, K., Muraki, S., Haba, R., Maeba, T., Suzuki, Y., & Yachida, S. (2013). Immunohistochemically detected expression of 3 major genes (CDKN2A\/p16, TP53, and SMAD4\/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Annals of Surgery, 258, 336\u2013346. https:\/\/doi.org\/10.1097\/SLA.0b013e3182827a65","journal-title":"Annals of Surgery"},{"key":"10004_CR173","first-page":"3126","volume":"57","author":"M Schutte","year":"1997","unstructured":"Schutte, M., Hruban, R. H., Geradts, J., Maynard, R., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte-Waldhoff, I., Schmiegel, W., Baylin, S. B., Kern, S. E., & Herman, J. G. (1997). Abrogation of the Rb\/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Research, 57, 3126\u20133130.","journal-title":"Cancer Research"},{"key":"10004_CR174","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1158\/1078-0432.CCR-09-0227","volume":"15","author":"A Blackford","year":"2009","unstructured":"Blackford, A., Serrano, O. K., Wolfgang, C. L., Parmigiani, G., Jones, S., Zhang, X., Parsons, D. W., Lin, J.C.-H., Leary, R. J., Eshleman, J. R., Goggins, M., Jaffee, E. M., Iacobuzio-Donahue, C. A., Maitra, A., Cameron, J. L., Olino, K., Schulick, R., Winter, J., Herman, J. M., \u2026 Hruban, R. H. (2009). SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clinical Cancer Research, 15, 4674\u20134679. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0227","journal-title":"Clinical Cancer Research"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-10004-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-021-10004-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-10004-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T08:16:16Z","timestamp":1644308176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-021-10004-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":174,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10004"],"URL":"https:\/\/doi.org\/10.1007\/s10555-021-10004-4","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}